Abstract
Long-term safety, tolerability, and effectiveness of TV-46000 —a long-acting subcutaneous antipsychotic (lasca)—in patients with schizophrenia: the phase 3 shine study
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
